Aug 13 : Researchers have reported that a previously unknown side effect of an unnamed drug currently on the marketplace could be useful for treating acne.

Aug 13 : Pfizer’s maraviroc, the first in a new class of HIV drugs formulated to stop HIV virus from entering the immune system, has been approved by the US Food and Drug Administration (FDA).

Aug 10: Biocon Ltd, India’s leading biotech firm, has entered into a licensing agreement with a US-based company to market a breast cancer drug in Pakistan, Bangladesh,

Aug 8 : Allergan Inc., the $3-billion US-based pharma major, has set up its research and development centre here to undertake global R&D projects in ophthalmology, neurology and urology.

Aug 8 : Angry British farmers are considering suing laboratory operators in Pirbright for millions of pounds in damages after an initial report into the cause of the foot-and-mouth outbreak suggested the virus might have escaped from their site, media reports said Wednesday.

July 30 : Biocon Ltd, India’s leading biotechnology firm, has entered into an agreement with Neopharma, a leading Abu Dhabi-based pharma company owned by an Indian

July 25 : The ScanBalt Campus (SBC) Molecular Diagnostics Knowledge Network announces today that the German Federal Ministry of Education and Research

July 18 : Biocon Ltd, India’s leading biotechnology firm, has decided to divest its enzymes business vertical to Novozymes A/S of Denmark for $115 million (Rs.4.7 billion) in an all-cash deal.

July 12 : Unique technology, that uses the enzymes of fireflies to read the genetic code of DNA, has been installed at the University of Liverpool.

July 12 : Suven Life Sciences has submitted an application with the Drug Controller General of India for permission to undertake phase-1 clinical trials of its new drug Suvn-502 for treatment of cognitive disorders such as Alzheimer’s and schizophrenia.